[Treatment with cephalexin monohydrate of urinary tract infections in the diabetic patient].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000209:etiology; D002386:Cataract / Q000209:etiology; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D048909:Diabetes Complications; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005128:Eye Diseases / Q000209:etiology; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002511:Cephalosporins
Tratamiento con monohidrato de cefalexina de las infecciones de las vías urinarias en el paciente diabético.